Differentiated Evaluation of Extract-Specific Evidence onCimicifuga racemosa's Efficacy and Safety for Climacteric Complaints
Authors:
Open Access
- 25 August 2013
- journal article
- review article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-21
Abstract
Past reviews onCimicifuga racemosa(CR) without differentiation between extracts, quality, and indication altogether led to inconsistent data. Therefore, for the first time, we meet the requirements of the system's logic of evidence-based phytotherapy by taking into consideration extracts, pharmaceutical quality (reflected in a regulatory status as medicinal product), and indication. A literature search for clinical studies examining CR's efficacy and safety for menopausal complaints was conducted. The results were sorted by type of extract, regulatory status, and indication. Accordingly, Oxford Levels of Evidence (LOE) and Grades of Recommendation (GR) were determined. CR extracts demonstrated a good to very good safety in general, on estrogen-sensitive organs and the liver. However, only registered CR medicinal products were able to prove their efficacy. Best evidence was provided by the isopropanolic CR extract (iCR): the multitude of studies including more than 11,000 patients demonstrated consistent confirmatory evidence of LOE 1b (LOE 1a for safety) leading to GR A. The studies on the ethanolic extract BNO 1055 including more than 500 patients showed exploratory evidence of LOE 2b resulting in GR B. A positive benefit-risk profile is stated and limited toCimicifuga racemosaproducts holding a marketing authorisation for treating climacteric complaints.Keywords
This publication has 62 references indexed in Scilit:
- Black Cohosh Hepatic Safety: Follow-Up of 107 Patients Consuming a SpecialCimicifuga racemosa rhizomeHerbal Extract and Review of LiteratureEvidence-Based Complementary and Alternative Medicine, 2011
- Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) CohortCancer Epidemiology, Biomarkers & Prevention, 2010
- Pharmacokinetics of 23-Epi-26-Deoxyactein in Women After Oral Administration of a Standardized Extract of Black CohoshClinical Pharmacology & Therapeutics, 2009
- Safety and efficacy of black cohosh and red clover for the management of vasomotor symptomsMenopause, 2009
- Randomized, Double-Blind, Placebo-Controlled Trial of Cimicifuga racemosa (Black Cohosh) in Women With Anxiety Disorder Due to MenopauseJournal of Clinical Psychopharmacology, 2009
- Black cohosh hepatotoxicityMenopause, 2009
- Black cohosh has central opioid activity in postmenopausal womenMenopause, 2008
- Evaluation of the Botanical Authenticity and Phytochemical Profile of Black Cohosh Products by High-Performance Liquid Chromatography with Selected Ion Monitoring Liquid Chromatography−Mass SpectrometryJournal of Agricultural and Food Chemistry, 2006
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002